1st Quarter - Report

AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety, prescription drug abuse, value of prescription drugs; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)

LobbyistCovered position, as disclosed
TRACY SPICER —

Bills named: H.R. 1968 (119th), S. 891 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.